Genital herpes simplex infection
HSV · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Genital herpes, usually HSV-2 (increasingly HSV-1), causes painful recurrent anogenital ulceration. Antiviral therapy shortens episodes and, taken suppressively, reduces recurrences and transmission; first episodes can be severe.
Red flags
- Urinary retention or severe sacral neuropathy
- Signs of aseptic meningitis/encephalitis
- Disseminated infection in immunosuppression
- Pregnancy near term (neonatal transmission risk)
- Very extensive ulceration with systemic illness
Assessment
Differential diagnosis
- Primary syphilis (painless ulcer)
- Chancroid
- Lymphogranuloma venereum
- Behcet disease / aphthous ulceration
- Fixed drug eruption
- Candidal or traumatic lesions
Investigations
- HSV PCR of ulcer swab (type-specific)
- Full STI screen (HIV, syphilis, gonorrhoea, chlamydia)
- HIV test (ulcers increase transmission)
- Pregnancy status assessment
- Type-specific serology in selected cases
- Assess for urinary retention / neurological involvement
Management
- Confirm with HSV PCR from a fresh lesion
- Classify as first episode or recurrence and assess severity
- Start oral antivirals promptly, especially in first episodes
- Provide analgesia, saline bathing and topical anaesthetic for comfort
- Screen for other STIs and HIV
- Counsel on natural history, asymptomatic shedding and transmission
- Discuss episodic versus suppressive therapy for recurrences
- Manage complications (urinary retention may need catheter, aseptic meningitis)
- In pregnancy, plan management to prevent neonatal herpes
- Offer suppressive therapy to reduce transmission to partners
- Advise condom use and partner notification discussion
- Arrange follow-up and psychological support as needed
Drugs & doses
Aciclovir 400 mg PO three times daily for 5-10 days (first episode)
Valaciclovir 500 mg PO twice daily for 5-10 days (first episode)
Aciclovir 800 mg PO three times daily for 2 days (episodic recurrence)
Valaciclovir 500 mg PO once daily (suppression)
Aciclovir 5-10 mg/kg IV every 8 h (severe/disseminated/CNS disease)
Disposition
Outpatient sexual health clinic; admit for severe/disseminated disease, retention or CNS involvement.
Complications & pitfalls
- Aseptic meningitis and autonomic neuropathy
- Secondary bacterial infection
- Neonatal herpes (high morbidity)
- Disseminated disease in immunocompromised
- Psychosexual distress
Exam pearls
- Suppressive valaciclovir reduces transmission to seronegative partners
- First-episode HSV-1 genital disease recurs less often than HSV-2
- Start aciclovir in pregnancy from 36 weeks if recurrent to reduce lesions at delivery
- Caesarean section advised for active lesions at labour, especially primary infection near term
- Immunocompromised patients may need higher/longer dosing and resistance consideration
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.